Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
The protein encoded by GKN1 is found to be down-regulated in human gastric cancer tissue as compared to normal gastric mucosa. Additionally we are shipping Gastrokine 1 Kits (31) and Gastrokine 1 Proteins (13) and many more products for this protein.
Showing 10 out of 89 products:
Human Monoclonal Gastrokine 1 Primary Antibody for WB - ABIN394553
Rose, Behm, Drgon, Johnson, Uhl: Personalized smoking cessation: interactions between nicotine dose, dependence and quit-success genotype score. in Molecular medicine (Cambridge, Mass.) 2010
Show all 5 references for ABIN394553
Human Monoclonal Gastrokine 1 Primary Antibody for ELISA, WB - ABIN566020
Rippa, La Monica, Allocca, Romano, De Palma, Arcari: Overexpression of gastrokine 1 in gastric cancer cells induces fas-mediated apoptosis. in 1970
Show all 5 references for ABIN566020
GKN1 may contribute to the maintenance of gastric epithelial homeostasis and inhibit gastric carcinogenesis by down-regulating the gastrin-cholecystokinin B receptor (show CCKBR Antibodies) signaling pathway.
Gastrokine 1 indirectly participates in actin stabilization since its overexpression in gastric cancer cells strongly increases the expression of tight and adherens junction proteins
AMP-18 appears to act through PI3K (show PIK3CA Antibodies)/AKT (show AKT1 Antibodies) pathways to increase p21 (show CDKN1A Antibodies) phosphorylation, thereby reducing its nuclear accumulation to overcome the antiproliferative effects of TNF-alpha (show TNF Antibodies).
Results suggest a potential association between CRP and GPC5 variants with lung cancer risk; variation in GKN1 is associated with chemotherapy response in the Chinese Han population.
GKN1 inhibits metastasis in gastric cancer cells.
GKN1 may shorten telomeres by acting as a potential c-myc (show MYC Antibodies) inhibitor that eventually leads to senescence and apoptosis in gastric cancer cells
GKN1 expression in the gastric mucosa of gastric cancer patients is decreased; this is associated with progression and prognosis of gastric cancer.
Data show that recombinant gastrokine 1 (GKN1) interacts with amyloid-beta peptide (1-40) preventing its aggregation.
These results suggest that GKN1 might be a target to inhibit the effects from H.pylori CagA (show S100A8 Antibodies).
Low GKN1 activity is associated with gastric cancers.
The protein encoded by this gene is found to be down-regulated in human gastric cancer tissue as compared to normal gastric mucosa.
, 18 kDa antrum mucosa protein
, protein CA11 homolog
, BRICHOS domain containing 1